Denali Therapeutics
South San Francisco, CA
Denali Therapeutics Inc. operates as a biotechnology company. The Company discovers and develops medicines for neurodegenerative diseases. Denali Therapeutics serves patients in the State of California.
denalitherapeutics.comCompany Details
Founded
- 2015
Employees
- 119 employees
Raised
- $445,423,008
Headquarters Location
- South San Francisco, CA
Public
- Yes
Acquired
- No
CEO
Sean McCarthy
Founders
- Patrick Daugherty
Company Collections
These are collections Denali Therapeutics is a part of. Click on the collection name to view similar companies.
Denali Therapeutics' Industries
Denali Therapeutics' Tech Stack
Denali Therapeutics Headquarters Location
151 Oyster Point Blvd suite 400, South San Francisco, CA 94080-1913
Total Amount Raised: $445,423,008
Denali Therapeutics Funding Rounds
Post Ipo Equity
$100,000,000
Post Ipo Equity Investors
Longitude CapitalOrbiMed AdvisorsVivo CapitalVenrock Healthcare Capital PartnersRTW InvestmentsPost Ipo Equity
$93,600,000
Post Ipo Equity
$116,900,000
Series D
$70,000,000
Series D Investors
Casdin CapitalCormorant Asset ManagementPerceptive AdvisorsRedmile GroupVenrockWellington ManagementTekla Capital ManagementDeerfield ManagementSeries C
$20,000,000
Series C Investors
Pfizer Venture InvestmentsThird Rock VenturesCanaan PartnersRoche Venture FundIPO
Unknown
Series B
$1,423,000
Series B
$11,000,000
Series B Investors
Canaan PartnersThird Rock VenturesSeries B
$30,000,000
Series B Investors
Third Rock VenturesRoche Venture FundConvertible Note
$2,500,000
Convertible Note Investors
Mike Panesis
Funding info provided by Diffbot.
Denali Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Denali Therapeutics.